Osborne Clarke advises Creo Medical Group on £36m fundraising
Bristol-based lawyers at international legal practice Osborne Clarke have advised Creo Medical Group, a medical device company based in Chepstow focused on the emerging field of surgical endoscopy, on a successful £36.3 million fundraising.
AIM-quoted Creo plans to use the proceeds from the fundraising to accelerate the commercial roll-out of its products globally, explore potential strategic acquisition opportunities and continue to develop its pipeline of commercial licensing and partnering opportunities.
The Osborne Clarke team that advised on the transaction was led by Bristol-based corporate partner Mark Wesker, who was assisted by associate Rebecca Ewing, associate Liam O’Connor and trainee solicitor Bethany Filby.
Mark Wesker also led the Osborne Clarke team which advised Creo on its £48 million fundraising in 2018 and the £52 million fundraising of the following year.
Osborne Clarke’s corporate team is considered the go-to practice for many businesses in the life sciences and healthcare sector. The team advises at every stage of company development across all corporate areas, from equity and debt fundraising to M&A, IPOs and JVs.
